Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Souheil Y. El-Chemaly"'
Autor:
Auyon J. Ghosh, MD, MPH, Matthew Moll, MD, MPH, Shikshya Shrestha, PhD, Sergio Poli, MD, Stephen J. Glatt, PhD, Hilary J. Goldberg, MD, Andrew M. Courtwright, MD, Souheil Y. El-Chemaly, MD
Publikováno v:
JHLT Open, Vol 4, Iss , Pp 100081- (2024)
Acute cellular rejection (ACR) is one of the main risk factors for chronic allograft dysfunction, the primary contributor to poor long-term survival in lung transplant recipients. We sought to develop a blood-based transcriptomic risk score (TRS) to
Externí odkaz:
https://doaj.org/article/bb29725f0f1b4a8fae559b9f86c175c5
Autor:
Konstantin Tsoyi, Anthony J. Esposito, Bo Sun, Ryan G. Bowen, Kevin Xiong, Fernando Poli, Rafael Cardenas, Sarah G. Chu, Xiaoliang Liang, Stefan W. Ryter, Christine Beeton, Tracy J. Doyle, Matthew J. Robertson, Lindsay J. Celada, Freddy Romero, Souheil Y. El-Chemaly, Mark A. Perrella, I.-Cheng Ho, Ivan O. Rosas
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract Rheumatoid arthritis (RA)-associated interstitial lung disease (RA-ILD) is the most common pulmonary complication of RA, increasing morbidity and mortality. Anti-citrullinated protein antibodies have been associated with the development and
Externí odkaz:
https://doaj.org/article/ec81a56a0af949f686db3bdeb3e61b1e
Autor:
Konstantin, Tsoyi, Anthony J, Esposito, Bo, Sun, Ryan G, Bowen, Kevin, Xiong, Fernando, Poli, Rafael, Cardenas, Sarah G, Chu, Xiaoliang, Liang, Stefan W, Ryter, Christine, Beeton, Tracy J, Doyle, Matthew J, Robertson, Lindsay J, Celada, Freddy, Romero, Souheil Y, El-Chemaly, Mark A, Perrella, I-Cheng, Ho, Ivan O, Rosas
Publikováno v:
Scientific reports. 12(1)
Rheumatoid arthritis (RA)-associated interstitial lung disease (RA-ILD) is the most common pulmonary complication of RA, increasing morbidity and mortality. Anti-citrullinated protein antibodies have been associated with the development and progressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::437e479d8790048d92a5b1660f1ffdab
https://pubmed.ncbi.nlm.nih.gov/35181688
https://pubmed.ncbi.nlm.nih.gov/35181688
Autor:
Anthony J Esposito, Jewel Imani, Shikshya Shrestha, Shefali Bagwe, Anthony M Lamattina, Marina Vivero, Hilary J Goldberg, Ivan O Rosas, Elizabeth P Henske, Souheil Y El-Chemaly
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 49, Iss 2 (2023)
ABSTRACT Objective: Lymphangioleiomyomatosis (LAM) is a rare, destructive disease of the lungs with a limited number of determinants of disease activity, which are a critical need for clinical trials. FGF23 has been implicated in several chronic pulm
Externí odkaz:
https://doaj.org/article/e5cce990267041748b35c5110d289225